These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11238646

  • 1. Topology and structure of the C1q-binding site on C-reactive protein.
    Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE.
    J Immunol; 2001 Mar 15; 166(6):3998-4004. PubMed ID: 11238646
    [Abstract] [Full Text] [Related]

  • 2. The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.
    Black S, Agrawal A, Samols D.
    Mol Immunol; 2003 Jun 15; 39(16):1045-54. PubMed ID: 12749911
    [Abstract] [Full Text] [Related]

  • 3. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
    Agrawal A, Volanakis JE.
    J Immunol; 1994 Jun 01; 152(11):5404-10. PubMed ID: 8189060
    [Abstract] [Full Text] [Related]

  • 4. A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide.
    Agrawal A, Simpson MJ, Black S, Carey MP, Samols D.
    J Immunol; 2002 Sep 15; 169(6):3217-22. PubMed ID: 12218140
    [Abstract] [Full Text] [Related]

  • 5. Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.
    Bally I, Inforzato A, Dalonneau F, Stravalaci M, Bottazzi B, Gaboriaud C, Thielens NM.
    Front Immunol; 2019 Sep 15; 10():461. PubMed ID: 30923526
    [Abstract] [Full Text] [Related]

  • 6. The physiological structure of human C-reactive protein and its complex with phosphocholine.
    Thompson D, Pepys MB, Wood SP.
    Structure; 1999 Feb 15; 7(2):169-77. PubMed ID: 10368284
    [Abstract] [Full Text] [Related]

  • 7. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A, Rovó Z, Papp D, Cervenak L, Varga L, Füst G, Thielens NM, Arlaud GJ, Prohászka Z.
    Immunology; 2007 May 15; 121(1):40-50. PubMed ID: 17244159
    [Abstract] [Full Text] [Related]

  • 8. Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis.
    Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C, Clos TW.
    J Biol Chem; 2005 Jul 01; 280(26):25095-102. PubMed ID: 15878871
    [Abstract] [Full Text] [Related]

  • 9. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H, Robey FA, Gewurz H.
    J Exp Med; 1992 May 01; 175(5):1373-9. PubMed ID: 1569403
    [Abstract] [Full Text] [Related]

  • 10. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX, Siegel JN, Gewurz H.
    J Immunol; 1991 Apr 01; 146(7):2324-30. PubMed ID: 2005402
    [Abstract] [Full Text] [Related]

  • 11. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
    Inforzato A, Peri G, Doni A, Garlanda C, Mantovani A, Bastone A, Carpentieri A, Amoresano A, Pucci P, Roos A, Daha MR, Vincenti S, Gallo G, Carminati P, De Santis R, Salvatori G.
    Biochemistry; 2006 Sep 26; 45(38):11540-51. PubMed ID: 16981714
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein: structural biology and host defense function.
    Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE.
    Clin Chem Lab Med; 1999 Mar 26; 37(3):265-70. PubMed ID: 10353470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T, Tengvall P.
    Biochem Biophys Res Commun; 2007 Jan 05; 352(1):251-8. PubMed ID: 17113035
    [Abstract] [Full Text] [Related]

  • 16. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
    Thommesen JE, Michaelsen TE, Løset GÅ, Sandlie I, Brekke OH.
    Mol Immunol; 2000 Nov 05; 37(16):995-1004. PubMed ID: 11395138
    [Abstract] [Full Text] [Related]

  • 17. Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.
    Agrawal A, Xu Y, Ansardi D, Macon KJ, Volanakis JE.
    J Biol Chem; 1992 Dec 15; 267(35):25353-8. PubMed ID: 1460031
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A.
    Eur J Immunol; 2003 Feb 15; 33(2):465-73. PubMed ID: 12645945
    [Abstract] [Full Text] [Related]

  • 19. The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.
    Gang TB, Hammond DJ, Singh SK, Ferguson DA, Mishra VK, Agrawal A.
    J Biol Chem; 2012 Dec 14; 287(51):43116-25. PubMed ID: 23139417
    [Abstract] [Full Text] [Related]

  • 20. Heme interacts with c1q and inhibits the classical complement pathway.
    Roumenina LT, Radanova M, Atanasov BP, Popov KT, Kaveri SV, Lacroix-Desmazes S, Frémeaux-Bacchi V, Dimitrov JD.
    J Biol Chem; 2011 May 06; 286(18):16459-69. PubMed ID: 21454703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.